China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
Russia says ‘great deal of noise’ present in media
-
EU allocates $188.2M to boost defense production under
-
Zelenskyy says US warned it'll cut off intelligence
-
Italian premier says Trump's Russian diesel deal
-
NATO chief says US-Ukraine intelligence sharing has not
-
Israeli artillery shelling targets several areas in
-
Bank of America profit falls 17% after $1.2B Treasury
-
3 injured in unidentified drone attack on fishing boat
